GE Healthcare and SOPHiA GENETICS to Collaborate to Match Treatments to Multimodal Patient Data and Cancer Type

Author's Avatar
Jul 06, 2021

GE Healthcare and SOPHiA+GENETICS today announced that they have signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient’s genomic profile and cancer type, helping to ensure the most effective and personalized treatment.